IO Biotech, Inc.IOBTNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +31.32% | +0.00% | +0.00% | +0.00% | +1.61% |
| Weighted Average Shares Diluted Growth | +31.32% | +0.00% | +0.00% | +0.00% | +1.61% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +1.05% | +0.53% | +1.43% | +10.78% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -47.87% | -55.08% | -64.31% | -62.03% | -55.58% |
| Book Value per Share Growth | -64.94% | -64.69% | -77.12% | -98.35% | -98.76% |
| Debt Growth | -22.44% | -23.22% | -23.88% | +288.65% | -27.93% |
| R&D Expense Growth | +14.29% | -2.86% | +14.42% | +5.07% | -31.90% |
| SG&A Expenses Growth | +8.62% | -10.22% | +5.41% | +14.86% | -12.06% |